SEC Tracker
Get the app

Protagonist Therapeutics PTGX

Protagonist Therapeutics: quarterly report for the quarter ended Jun 30, 2021

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Protagonist Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Prestige Consumer Healthcare PBH public float $3.0B, Sep 30, 2025
  2. Catalyst Pharmaceuticals CPRX public float $2.5B, Jun 30, 2025
  3. Cytokinetics CYTK public float $2.5B, Jun 30, 2025
  4. TG Therapeutics TGTX public float $2.5B, Jun 30, 2025
  5. Acadia Pharmaceuticals ACAD public float $2.3B, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.